𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Faraday shield for surface-coil studies of subcutaneous tumors

✍ Scribed by T.C Ng; W.T Evanochko; J.D Glickson

Publisher
Elsevier Science
Year
1982
Weight
290 KB
Volume
49
Category
Article
ISSN
0022-2364

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Shielded solenoidal probe for in Vivo NM
Shielded solenoidal probe for in Vivo NMR studies of solid tumors
✍ Thian C. Ng; Jerry D. Glickson πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 421 KB

## Abstract A shielded solenoidal probe, suitable for __in vivo__ NMR studies of subcutancous solid tumors, is described. The ^31^P NMR spectra obtained from phantom samples and __in vivo__ subeutaneous solid tumors in mice show that spurious signals from the body are totally eliminated if the prop

Golimumab, a human anti–tumor necrosis f
Golimumab, a human anti–tumor necrosis factor Ξ± monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis
✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 135 KB πŸ‘ 1 views
Erratum: Golimumab, a human anti-tumor n
Erratum: Golimumab, a human anti-tumor necrosis factor Ξ± monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis
✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 38 KB πŸ‘ 1 views